← Leaderboards
Rongbao Li
Southern Research Institute
$2,841,782
Attributed
$2,841,782
Total exposure
12
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $552.6K · FY2005–10$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$2,841,782 · 12
By mechanism
R01$1,396,147 · 1
R21$1,357,873 · 3
P41$87,762 · 8
Top collaborators
No co-investigators on record.
Most similar at Southern Research Institute
Same institution · by research overlap
- William B Parker$3,366,132
Others in their field
Top investigators on “Enzyme Activity”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Randall J Bateman · Washington University$47,808,754
- Susan Abushakra · Alzheon, Inc.$47,265,244
- David Heimbrook · Leidos Biomedical Research, Inc.$45,964,082
- Stuart L Schreiber · Harvard University (Medical School)$40,631,496
- Keith O Hodgson · Stanford University$37,935,767
Research focus
Enzyme ActivityStructureLeadTuberculosisEnzyme StructureMycobacterium TuberculosisResearch PersonnelEnzymesResourcesBasePathway InteractionsAntimicrobialTuberculosis TreatmentNucleoside AnalogStructural BiologyMolecularComplexProteinsNucleosidesAdenosine KinaseAnalogPathogenAntimycobacterial AgentsMulti-Drug Resistance
Grant awards (17)
Structure of M. tuberculosis Adenosine Kinase and Design of Antimicrobial Nucle$352,792
R01 · FY2010 · AI · contact PI
M. tuberculosis Adenosine Kinase and Design of Antimicrobial Nucleoside Analogs$350,864
R01 · FY2009 · AI · contact PI
M TUBERCULOSIS ADENOSINE KINASE AND ANTI-MICROBIAL NUCLEOSIDE ANALOGS$6,443
P41 · FY2009 · RR · contact PI
Structure of M. tuberculosis Adenosine Kinase and Design of Antimicrobial Nucle$345,536
R01 · FY2008 · AI · contact PI
M TUBERCULOSIS ADENOSINE KINASE AND ANTI-MICROBIAL NUCLEOSIDE ANALOGS$3,729
P41 · FY2008 · RR · contact PI
STRUCTURE AND FUNCTION OF PYK2 IN INTEGRIN SIGNALING$3,523
P41 · FY2008 · RR · contact PI
Mycobacterium tubercolosis Adenosine Kinase Design Antimicrobial Nucleoside Anal$346,955
R01 · FY2007 · AI · contact PI
HTS Assay Development for Discovery of Specific PYK2 Inhibitors$205,652
R21 · FY2007 · NS · contact PI
M TUBERCULOSIS ADENOSINE KINASE AND ANTI-MICROBIAL NUCLEOSIDE ANALOGS$1,489
P41 · FY2006 · RR · contact PI
STRUCTURE AND FUNCTION OF PYK2 IN INTEGRIN SIGNALING$665
P41 · FY2006 · RR · contact PI
STRUCTURAL STUDIES OF M TUBERCULOSIS ADENOSINE KINASE$31,884
P41 · FY2005 · RR
NOVEL POTENT AND SELECTIVE ANTIFOLATE DEVELOPMENT FOR TB TREATMENT$31,863
P41 · FY2005 · RR
DEVELOPMENT OF B ANTHRACIS DHFR AS A THERAPEUTIC TARGET FOR ANTHRAX$8,166
P41 · FY2005 · RR
Novel Antifolates against AIDS-associated Tuberculosis$360,722
R21 · FY2004 · AI
PYK2 &Therapeutic Strategies-Cancer-induced Osteolysis$214,462
R21 · FY2004 · CA
Novel Antifolates against AIDS-associated Tuberculosis$361,367
R21 · FY2003 · AI
PYK2 &Therapeutic Strategies-Cancer-induced Osteolysis$215,670
R21 · FY2003 · CA